Skip to content

10x Genomics, Inc. TXG Standard and Extended Product Warranty Accrual

Standard and Extended Product Warranty Accrual at other companies

Illumina logo
IlluminaILMN
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProductWarrantyAccrual.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s standard and extended product warranty accrual.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s standard and extended product warranty accrual?
10x Genomics, Inc. (TXG) reported standard and extended product warranty accrual of $5.69M in Q1 2026.
How has 10x Genomics, Inc.'s standard and extended product warranty accrual changed year-over-year?
10x Genomics, Inc.'s standard and extended product warranty accrual decreased by 39.8% year-over-year, from $9.45M to $5.69M.
What is the long-term trend for 10x Genomics, Inc.'s standard and extended product warranty accrual?
Over 5 years (2020 to 2025), 10x Genomics, Inc.'s standard and extended product warranty accrual has grown at a 76.5% compound annual growth rate (CAGR), from $399K to $6.83M.